Two novel molecular defects in the LCAT gene are associated with fish eye disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 2, 1996, Pages 294-303

  Kuivenhoven, Jan Albert ^a   Stalenhoef, Anton F H ^b   Hill, John S ^c   Demacker, Pierre N M ^a,b,c,d   Errami, A ^a   Kastelein, John J P ^a   Pritchard, P Haydn ^c,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d ST PAUL S HOSPITAL   (Canada)

Author keywords

corneal opacities; fish eye disease; HDL deficiency; lecithin:cholesterol acyltransferase

Indexed keywords

ARGININE; GLUTAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PROLINE;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL ESTERIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA OPACITY; CORONARY ARTERY DISEASE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; MALE; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; TANGIER DISEASE;

EID: 0030019949     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.2.294     Document Type: Article

References (33)

1. Carlson LA, Philipson B. Fish-eye disease: a new familial condition with massive corneal opacities and dyslipoproteinemia. Lancet. 1979;2:921-923.
2. Skretting G, Prydz H. An amino acid exchange in exon I of the human lecithin:cholesterol acyltransferase (LCAT) gene is associated with fish eye disease. Biochem Biophys Res Commun. 1992;182:583-587.
3. Klein HG, Lohse P, Pritchard PH, Bojanovski D, Schmidt H, Brewer HB Jr. Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome: lecithin-cholesterol acyltransferase (Thr-123-Ile) and lecithin-cholesterol acyltransferase (Thr-347-Met). J Clin Invest. 1992;89:499-506.
4. Klein HG, Santamarina-Fojo S, Duverger N, Clerc M, Dumon MF, Albers JJ, Marcovina S, Brewer HB Jr. Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity - implications for classification and prognosis. J Clin Invest. 1993;92:479-485.
5. Funke H, von Eckardstein A, Pritchard PH, Albers JJ, Kastelein JJP, Droste C, Assmann G. A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltrans- ferase (LCAT) leads to the selective loss of alpha-LCAT activity. Proc Natl Acad Sci U S A. 1991;88:4855-4859.
6. Von Eckardstein A, Funke H, Pritchard PH, Albers JJ, Kastelein JJP, Droste C, Assmann G. Fish-eye disease: characterization of the molecular defect. Circulation. 1990;82:425. Abstract.
7. Funke H, von Eckardstein A, Pritchard PH, Hornby AE, Wiebusch H, Motti C, Hayden MR, Dachet C, Jacotot B, Gerdes U, Faergeman O, Albers JJ, Colleoni N, Catapano A, Frohlich J, Assmann G. Genetic and phenotypic heterogeneity in familial lecithin:cholesterol acyltransferase (LCAT) deficiency: six newly identified defective alleles further contribute to the structural heterogeneity in this disease. J Clin Invest. 1993;91:677-683.
8. Klein HG, Lohse P, Duverger N, Albers JJ, Rader DJ, Zech LA, Santamarina-Fojo S, Brewer HB Jr. Two different allelic mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in classic LCAT deficiency: LCAT (tyr83 to stop) and LCAT (tyr156 to asn). J Lipid Res. 1993;34:49-58.
9. Bujo H, Kusunoki J, Ogasawara M, Yamamoto T, Ohta Y, Shimada T, Saito Y, Yoshida S. Molecular defect in familial lecithin:cholesterol acyltransferase (LCAT) deficiency: a single nucleotide insertion in LCAT gene causes a complete deficient type of the disease. Biochem Biophys Res Commun. 1991;181:933-940.
10. Taramelli R, Pontoglio M, Candiani G, Ottolenghi S, Dieplinger H, Catapano A, Albers J, Vergani C, McLean J. Lecithin cholesterol acyltransferase deficiency: molecular analysis of a mutated allele. Hum Genet. 1990;85:195-199.
11. Gotoda T, Yamada N, Murase T, Sakuma M, Murayama N, Shimano H, Kozaki K, Albers JJ, Yazaki Y, Akanuma Y. Differential phenotypic expression by three mutant alleles in familial lecithin:cholesterol acyltransferase deficiency. Lancet. 1991;338:778-781.
12. Maeda E, Naka Y, Matozaki T, Sakuma M, Akanuma Y, Yoshino G, Kasuga M. Lecithin-cholesterol acyltransferase (LCAT) deficiency with a missense mutation in exon 6 of the LCAT gene. Biochem Biophys Res Commun. 1991;178:460-466.
13. Assmann G, von Eckardstein A, Funke H. Lecithin:cholesterol acyltransferase deficiency and fish-eye disease. Curr Opin Lipidol. 1991;2:110-117.
14. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975;98:503-517.
15. Hayden MR, Kirk H, Clark C, Frohlich J, Rabkin S, MacLeod R, Hewitt J. DNA polymorphisms in and around the APO-AI-CIII genes and genetic hyperlipidemia. Am J Hum Genet. 1987;40:421-430.
16. Demacker PNM, Hijmans AG, Vos-Janssen HE, Van 't Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol in high density lipoprotein. Clin Chem. 1980;26:1775-1779.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
18. Demacker PNM, van Sommeren-Zondag DF, Stalenhoef AFH, Stuyt PMJ, van 't Laar A. Ultracentrifugation in swinging-bucket and fixed-angle rotors evaluated for isolation and determination of high-density lipoprotein subfraction HDL2 and HDL3. Clin Chem. 1983;29:656-663.
19. Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin Chem. 1990;36:1431-1435.
20. Frohlich J, McLeod R, Pritchard PH, Fesmire J, McConathy W. Plasma lipoprotein abnormalities in heterozygotes for familial lecithin:cholesterol acyltransferase deficiency. Metabolism. 1988;37:3-8.
21. Albers JJ, Adolphson JC, Chen CH. Radioimmunoassay of human lecithin-cholesterol acyltransferase. J Clin Invest. 1981;67:141-148.
22. Dobiasova M, Schutzova M. Cold labelled substrate and estimation of cholesterol esterification rate in lecithin cholesterol acyltransferase radioassay. Physiol Bohemoslov. 1986;35:319-327.
23. Warnick GR, Nguyen T, Albers AA. Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem. 1985;31:217-222.
24. Burnstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970;11:583-595.
25. Stokke KT, Norum KR. Determination of LCAT in human blood plasma. Scand J Clin Lab Invest. 1971;27:21-27.
26. Hill JS, O K, Wang X, Paranjape S, Dimitrijevich D, Lacko AG, Pritchard PH. Expression and characterization of recombinant human lectithin: cholesterol acyltransferase. J Lipid Res. 1993;34:1245-1251.
27. O K, Hill JS, Wang X, Pritchard PH. Recombinant lecithin:cholesterol acyltransferase containing a Thr123 to Ile mutation esterifies cholesterol in low density lipoprotein but not in high density lipoprotein. J Lipid Res. 1993;34:81-88.
28. Kuivenhoven JA, Wiebusch H, van Voorst tot Voorst E, Hill JS, Pritchard PH, Funke H, Kastelein JJP. Fish-eye disease and LCAT deficiency, extremes of one phenotype: a novel LCAT-mutation in a large family of Dutch descent. Atherosclerosis. 1994;109:230. Abstract.
29. Carlson LA. Fish-eye disease: a new familial condition with massive corneal opacities and dyslipoproteinemia. Eur J Clin Invest. 1982;12:41-53.
30. Frohlich J, Hoag G, McLeod R, Hayden M, Godin DV, Wadsworth LD, Critchley JD, Pritchard PH. Hypoalphalipoproteinemia resembling fish eye disease. Acta Med Scand. 1987;221:291-298.
31. Kastelein JJP, Pritchard PH, Erkelens DW, Kuivenhoven JA, Albers JJ, Frohlich JJ. Familial high-density-lipoprotein deficiency causing corneal opacities (fish-eye disease) in a family of Dutch descent. J Intern Med, 1992;231:413-419.
32. Clerc M, Dumon MF, Sess D, Freneix Clerc M, Mackness M, Conri C. A 'fish-eye disease' familial condition with massive corneal opacities and hypoalpha-lipoproteinaemia: clinical, biochemical and genetic features. Eur J Clin Invest. 1991;21:616-624.
33. Rader DJ, Ikewaki K, Duverger N, Schmidt H, Pritchard PH, Frohlich JJ, Clerc M, Dumon MF, Fairwell T, Zech L, Santamarina-Fojo S, Brewer HB Jr. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin:cholesterol acyltransferase deficiency and fish-eye disease. J Clin Invest. 1994;93:321-330.